Subnetwork | Dataset | Score | p-value 1 | p-value 2 | p-value 3 | Size | Highlighted genes |
---|---|---|---|---|---|---|---|
int-snw-90019 | chia-screen-data-Fav | 2.833 | 1.75e-15 | 4.97e-04 | 3.45e-03 | 12 | 11 |
reg-snw-11051 | chia-screen-data-Fav | 2.307 | 7.93e-08 | 2.35e-02 | 1.87e-02 | 25 | 17 |
Gene Symbol | Entrez Gene ID | Frequency | chia-screen-data-Fav gene score | Best subnetwork score | Degree | Chia-Hits Primary | Chia-Hits Secondary |
---|---|---|---|---|---|---|---|
PHB | 5245 | 12 | -2.743 | 2.689 | 163 | Yes | Yes |
MED28 | 80306 | 6 | -2.404 | 2.445 | 86 | Yes | - |
CBLL1 | 79872 | 6 | -1.897 | 2.445 | 38 | - | - |
MED13L | 23389 | 8 | -2.550 | 2.307 | 50 | Yes | - |
VARS | 7407 | 8 | -2.366 | 2.689 | 204 | Yes | - |
APC | 324 | 6 | -2.293 | 3.004 | 384 | Yes | - |
POU5F1 | 5460 | 12 | -5.148 | 3.538 | 179 | Yes | Yes |
ADA | 100 | 2 | -2.499 | 2.307 | 8 | Yes | Yes |
FBXO22 | 26263 | 8 | -1.739 | 2.459 | 208 | - | - |
EIF2S2 | 8894 | 9 | -2.999 | 2.459 | 103 | Yes | Yes |
HNRNPD | 3184 | 3 | -2.153 | 3.117 | 123 | Yes | - |
ETF1 | 2107 | 7 | -2.829 | 2.503 | 77 | Yes | Yes |
CCT7 | 10574 | 10 | -2.335 | 2.459 | 173 | Yes | - |
HNRNPU | 3192 | 12 | -2.869 | 2.644 | 172 | Yes | - |
CPSF3 | 51692 | 7 | -2.686 | 2.503 | 31 | Yes | Yes |
PRPF40A | 55660 | 4 | -1.511 | 2.307 | 305 | - | - |
NDUFA4L2 | 56901 | 10 | -2.477 | 2.459 | 21 | Yes | - |
AGPS | 8540 | 6 | -2.424 | 2.410 | 27 | Yes | Yes |
NFIA | 4774 | 2 | -1.458 | 2.307 | 80 | - | - |
YAP1 | 10413 | 12 | -4.256 | 3.538 | 53 | Yes | - |
NFIB | 4781 | 2 | -1.505 | 2.307 | 40 | - | - |
MATR3 | 9782 | 2 | -1.556 | 2.329 | 47 | - | - |
ULK2 | 9706 | 3 | -2.292 | 3.197 | 312 | Yes | Yes |
TPR | 7175 | 3 | -2.638 | 2.445 | 64 | Yes | Yes |
NUDT21 | 11051 | 2 | -1.273 | 2.307 | 61 | - | - |
NCBP1 | 4686 | 8 | -2.510 | 2.459 | 84 | Yes | Yes |
SYNCRIP | 10492 | 8 | -2.401 | 2.503 | 247 | Yes | Yes |
EIF2S1 | 1965 | 2 | -1.801 | 2.410 | 63 | - | - |
SRSF3 | 6428 | 5 | -2.992 | 3.538 | 54 | Yes | - |
GPS1 | 2873 | 10 | -3.621 | 2.689 | 62 | Yes | Yes |
POLH | 5429 | 8 | -2.586 | 2.459 | 24 | Yes | Yes |
SYT8 | 90019 | 3 | -1.382 | 2.833 | 1 | - | - |
DDIT3 | 1649 | 11 | -2.825 | 3.504 | 343 | Yes | Yes |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
ETF1 | 2107 | SYNCRIP | 10492 | pd | < | reg.ITFP.txt: no annot |
NCBP1 | 4686 | FBXO22 | 26263 | pd | < | reg.ITFP.txt: no annot |
PHB | 5245 | VARS | 7407 | pd | < | reg.ITFP.txt: no annot |
GPS1 | 2873 | PHB | 5245 | pd | > | reg.ITFP.txt: no annot |
APC | 324 | CCT7 | 10574 | pp | -- | int.I2D: Jorgensen_EphR, SOURAV_MAPK_LOW, IntAct |
EIF2S1 | 1965 | ETF1 | 2107 | pd | > | reg.ITFP.txt: no annot |
EIF2S1 | 1965 | ETF1 | 2107 | pp | -- | int.I2D: YeastLow |
APC | 324 | PHB | 5245 | pp | -- | int.I2D: Jorgensen_EphR |
NUDT21 | 11051 | PRPF40A | 55660 | pd | < | reg.ITFP.txt: no annot |
ULK2 | 9706 | SYNCRIP | 10492 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
NCBP1 | 4686 | TPR | 7175 | pd | < | reg.ITFP.txt: no annot |
POLH | 5429 | FBXO22 | 26263 | pd | < | reg.ITFP.txt: no annot |
HNRNPU | 3192 | MATR3 | 9782 | pd | < | reg.ITFP.txt: no annot |
APC | 324 | TPR | 7175 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid, IntAct, SOURAV_MAPK_HIGH |
HNRNPD | 3184 | ULK2 | 9706 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
NCBP1 | 4686 | CBLL1 | 79872 | pd | < | reg.ITFP.txt: no annot |
CCT7 | 10574 | FBXO22 | 26263 | pd | < | reg.ITFP.txt: no annot |
CBLL1 | 79872 | MED28 | 80306 | pd | > | reg.ITFP.txt: no annot |
EIF2S1 | 1965 | SYNCRIP | 10492 | pd | <> | reg.ITFP.txt: no annot |
ULK2 | 9706 | MATR3 | 9782 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
POU5F1 | 5460 | MATR3 | 9782 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
HNRNPU | 3192 | ULK2 | 9706 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
DDIT3 | 1649 | HNRNPU | 3192 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
HNRNPU | 3192 | YAP1 | 10413 | pp | -- | int.I2D: HPRD; int.HPRD: in vitro, in vivo |
CCT7 | 10574 | PRPF40A | 55660 | pp | -- | int.I2D: BioGrid, Pawson1 |
NFIB | 4781 | NUDT21 | 11051 | pd | > | reg.ITFP.txt: no annot |
HNRNPU | 3192 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
POU5F1 | 5460 | SRSF3 | 6428 | pp | -- | int.I2D: BioGrid |
DDIT3 | 1649 | VARS | 7407 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
NFIA | 4774 | NFIB | 4781 | pd | <> | reg.ITFP.txt: no annot |
AGPS | 8540 | SYNCRIP | 10492 | pd | < | reg.ITFP.txt: no annot |
MED13L | 23389 | MED28 | 80306 | pp | -- | int.I2D: BioGrid |
HNRNPD | 3184 | HNRNPU | 3192 | pp | -- | int.Mint: MI:0915(physical association) |
ETF1 | 2107 | EIF2S2 | 8894 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
NFIA | 4774 | NUDT21 | 11051 | pd | > | reg.ITFP.txt: no annot |
YAP1 | 10413 | MED28 | 80306 | pp | -- | int.I2D: MINT; int.Mint: MI:0915(physical association) |
HNRNPU | 3192 | PRPF40A | 55660 | pd | < | reg.ITFP.txt: no annot |
HNRNPU | 3192 | PRPF40A | 55660 | pp | -- | int.I2D: BioGrid, Pawson1 |
EIF2S1 | 1965 | EIF2S2 | 8894 | pp | -- | int.Intact: MI:0407(direct interaction); int.I2D: BCI, BioGrid_Yeast, IntAct, IntAct_Yeast, MINT_Yeast, YeastHigh, Yu_GoldStd, HPRD; int.HPRD: in vitro |
SRSF3 | 6428 | ULK2 | 9706 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
SYNCRIP | 10492 | CPSF3 | 51692 | pd | > | reg.ITFP.txt: no annot |
MATR3 | 9782 | NUDT21 | 11051 | pd | > | reg.ITFP.txt: no annot |
NFIA | 4774 | MED13L | 23389 | pd | > | reg.ITFP.txt: no annot |
SYNCRIP | 10492 | NUDT21 | 11051 | pd | > | reg.ITFP.txt: no annot |
NFIB | 4781 | AGPS | 8540 | pd | > | reg.ITFP.txt: no annot |
TPR | 7175 | NUDT21 | 11051 | pd | > | reg.ITFP.txt: no annot |
NUDT21 | 11051 | CBLL1 | 79872 | pd | < | reg.ITFP.txt: no annot |
NCBP1 | 4686 | PRPF40A | 55660 | pp | -- | int.I2D: INTEROLOG |
HNRNPD | 3184 | SYNCRIP | 10492 | pp | -- | int.I2D: HPRD, BCI; int.HPRD: in vivo |
VARS | 7407 | FBXO22 | 26263 | pd | <> | reg.ITFP.txt: no annot |
PHB | 5245 | FBXO22 | 26263 | pd | < | reg.ITFP.txt: no annot |
HNRNPU | 3192 | SYNCRIP | 10492 | pp | -- | int.Mint: MI:0915(physical association) |
FBXO22 | 26263 | NDUFA4L2 | 56901 | pd | > | reg.ITFP.txt: no annot |
APC | 324 | SYNCRIP | 10492 | pp | -- | int.I2D: Jorgensen_EphR |
EIF2S1 | 1965 | NUDT21 | 11051 | pd | > | reg.ITFP.txt: no annot |
ADA | 100 | NFIA | 4774 | pd | < | reg.pazar.txt: no annot |
APC | 324 | MATR3 | 9782 | pp | -- | int.I2D: Jorgensen_EphR |
DDIT3 | 1649 | HNRNPD | 3184 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
EIF2S2 | 8894 | FBXO22 | 26263 | pd | < | reg.ITFP.txt: no annot |
SYNCRIP | 10492 | SYT8 | 90019 | pp | -- | int.I2D: BioGrid, HPRD; int.HPRD: in vitro, in vivo |
NUDT21 | 11051 | FBXO22 | 26263 | pd | < | reg.ITFP.txt: no annot |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0008380 | RNA splicing | 1.51e-08 | 2.46e-04 | 4.092 | 8 | 14 | 232 |
GO:0003723 | RNA binding | 2.40e-08 | 3.91e-04 | 3.648 | 9 | 15 | 355 |
GO:0000398 | mRNA splicing, via spliceosome | 3.25e-08 | 5.31e-04 | 4.391 | 7 | 9 | 165 |
GO:0010467 | gene expression | 4.29e-08 | 7.00e-04 | 3.024 | 11 | 27 | 669 |
GO:0044822 | poly(A) RNA binding | 7.00e-08 | 1.14e-03 | 2.576 | 13 | 27 | 1078 |
GO:0005654 | nucleoplasm | 8.42e-08 | 1.37e-03 | 2.554 | 13 | 31 | 1095 |
GO:0031124 | mRNA 3'-end processing | 1.47e-06 | 2.40e-02 | 5.558 | 4 | 4 | 42 |
GO:0006369 | termination of RNA polymerase II transcription | 1.95e-06 | 3.18e-02 | 5.458 | 4 | 4 | 45 |
GO:0030529 | ribonucleoprotein complex | 3.09e-06 | 5.04e-02 | 4.439 | 5 | 6 | 114 |
GO:0005515 | protein binding | 8.84e-06 | 1.44e-01 | 1.013 | 25 | 77 | 6127 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 1.19e-05 | 1.94e-01 | 8.365 | 2 | 2 | 3 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.84e-05 | 3.00e-01 | 3.026 | 7 | 14 | 425 |
GO:0070934 | CRD-mediated mRNA stabilization | 3.95e-05 | 6.45e-01 | 7.628 | 2 | 2 | 5 |
GO:0070937 | CRD-mediated mRNA stability complex | 5.92e-05 | 9.66e-01 | 7.365 | 2 | 2 | 6 |
GO:0006379 | mRNA cleavage | 1.77e-04 | 1.00e+00 | 6.628 | 2 | 2 | 10 |
GO:0006396 | RNA processing | 2.38e-04 | 1.00e+00 | 4.628 | 3 | 4 | 60 |
GO:0006406 | mRNA export from nucleus | 2.63e-04 | 1.00e+00 | 4.581 | 3 | 5 | 62 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 3.05e-04 | 1.00e+00 | 6.250 | 2 | 2 | 13 |
GO:0044212 | transcription regulatory region DNA binding | 3.76e-04 | 1.00e+00 | 3.532 | 4 | 5 | 171 |
GO:0005829 | cytosol | 8.79e-04 | 1.00e+00 | 1.327 | 13 | 38 | 2562 |
GO:0006378 | mRNA polyadenylation | 8.93e-04 | 1.00e+00 | 5.491 | 2 | 2 | 22 |
GO:0001649 | osteoblast differentiation | 9.18e-04 | 1.00e+00 | 3.965 | 3 | 3 | 95 |
GO:0043022 | ribosome binding | 1.45e-03 | 1.00e+00 | 5.143 | 2 | 2 | 28 |
GO:0007094 | mitotic spindle assembly checkpoint | 1.78e-03 | 1.00e+00 | 4.996 | 2 | 3 | 31 |
GO:0042594 | response to starvation | 1.89e-03 | 1.00e+00 | 4.950 | 2 | 3 | 32 |
GO:1901673 | regulation of spindle assembly involved in mitosis | 2.02e-03 | 1.00e+00 | 8.950 | 1 | 1 | 1 |
GO:0043578 | nuclear matrix organization | 2.02e-03 | 1.00e+00 | 8.950 | 1 | 1 | 1 |
GO:2000016 | negative regulation of determination of dorsal identity | 2.02e-03 | 1.00e+00 | 8.950 | 1 | 1 | 1 |
GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis | 2.02e-03 | 1.00e+00 | 8.950 | 1 | 1 | 1 |
GO:0010965 | regulation of mitotic sister chromatid separation | 2.02e-03 | 1.00e+00 | 8.950 | 1 | 1 | 1 |
GO:0008609 | alkylglycerone-phosphate synthase activity | 2.02e-03 | 1.00e+00 | 8.950 | 1 | 1 | 1 |
GO:0006404 | RNA import into nucleus | 2.02e-03 | 1.00e+00 | 8.950 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 2.02e-03 | 1.00e+00 | 8.950 | 1 | 1 | 1 |
GO:0006157 | deoxyadenosine catabolic process | 2.02e-03 | 1.00e+00 | 8.950 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 2.02e-03 | 1.00e+00 | 8.950 | 1 | 1 | 1 |
GO:0046111 | xanthine biosynthetic process | 2.02e-03 | 1.00e+00 | 8.950 | 1 | 1 | 1 |
GO:0032261 | purine nucleotide salvage | 2.02e-03 | 1.00e+00 | 8.950 | 1 | 1 | 1 |
GO:0042483 | negative regulation of odontogenesis | 2.02e-03 | 1.00e+00 | 8.950 | 1 | 1 | 1 |
GO:0060169 | negative regulation of adenosine receptor signaling pathway | 2.02e-03 | 1.00e+00 | 8.950 | 1 | 1 | 1 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 2.02e-03 | 1.00e+00 | 8.950 | 1 | 1 | 1 |
GO:0006260 | DNA replication | 2.02e-03 | 1.00e+00 | 3.569 | 3 | 4 | 125 |
GO:0051171 | regulation of nitrogen compound metabolic process | 2.02e-03 | 1.00e+00 | 8.950 | 1 | 1 | 1 |
GO:0021740 | principal sensory nucleus of trigeminal nerve development | 2.02e-03 | 1.00e+00 | 8.950 | 1 | 1 | 1 |
GO:0008079 | translation termination factor activity | 2.02e-03 | 1.00e+00 | 8.950 | 1 | 1 | 1 |
GO:0060407 | negative regulation of penile erection | 2.02e-03 | 1.00e+00 | 8.950 | 1 | 1 | 1 |
GO:0031453 | positive regulation of heterochromatin assembly | 2.02e-03 | 1.00e+00 | 8.950 | 1 | 1 | 1 |
GO:0061141 | lung ciliated cell differentiation | 2.02e-03 | 1.00e+00 | 8.950 | 1 | 1 | 1 |
GO:0000166 | nucleotide binding | 2.11e-03 | 1.00e+00 | 2.863 | 4 | 6 | 272 |
GO:0016592 | mediator complex | 2.26e-03 | 1.00e+00 | 4.821 | 2 | 5 | 35 |
GO:0005634 | nucleus | 2.35e-03 | 1.00e+00 | 0.883 | 18 | 55 | 4828 |
GO:0035019 | somatic stem cell maintenance | 2.95e-03 | 1.00e+00 | 4.628 | 2 | 2 | 40 |
GO:0044267 | cellular protein metabolic process | 2.96e-03 | 1.00e+00 | 2.321 | 5 | 7 | 495 |
GO:0006974 | cellular response to DNA damage stimulus | 3.92e-03 | 1.00e+00 | 3.231 | 3 | 4 | 158 |
GO:0004832 | valine-tRNA ligase activity | 4.04e-03 | 1.00e+00 | 7.950 | 1 | 1 | 2 |
GO:0002314 | germinal center B cell differentiation | 4.04e-03 | 1.00e+00 | 7.950 | 1 | 1 | 2 |
GO:0060242 | contact inhibition | 4.04e-03 | 1.00e+00 | 7.950 | 1 | 1 | 2 |
GO:0031990 | mRNA export from nucleus in response to heat stress | 4.04e-03 | 1.00e+00 | 7.950 | 1 | 1 | 2 |
GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process | 4.04e-03 | 1.00e+00 | 7.950 | 1 | 1 | 2 |
GO:0006154 | adenosine catabolic process | 4.04e-03 | 1.00e+00 | 7.950 | 1 | 1 | 2 |
GO:0005846 | nuclear cap binding complex | 4.04e-03 | 1.00e+00 | 7.950 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 4.04e-03 | 1.00e+00 | 7.950 | 1 | 1 | 2 |
GO:0006438 | valyl-tRNA aminoacylation | 4.04e-03 | 1.00e+00 | 7.950 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 4.04e-03 | 1.00e+00 | 7.950 | 1 | 1 | 2 |
GO:0070840 | dynein complex binding | 4.04e-03 | 1.00e+00 | 7.950 | 1 | 1 | 2 |
GO:0046103 | inosine biosynthetic process | 4.04e-03 | 1.00e+00 | 7.950 | 1 | 1 | 2 |
GO:0060965 | negative regulation of gene silencing by miRNA | 4.04e-03 | 1.00e+00 | 7.950 | 1 | 1 | 2 |
GO:0046832 | negative regulation of RNA export from nucleus | 4.04e-03 | 1.00e+00 | 7.950 | 1 | 1 | 2 |
GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 4.04e-03 | 1.00e+00 | 7.950 | 1 | 1 | 2 |
GO:0001883 | purine nucleoside binding | 4.04e-03 | 1.00e+00 | 7.950 | 1 | 1 | 2 |
GO:0000189 | MAPK import into nucleus | 4.04e-03 | 1.00e+00 | 7.950 | 1 | 1 | 2 |
GO:0043558 | regulation of translational initiation in response to stress | 4.04e-03 | 1.00e+00 | 7.950 | 1 | 1 | 2 |
GO:2000791 | negative regulation of mesenchymal cell proliferation involved in lung development | 4.04e-03 | 1.00e+00 | 7.950 | 1 | 1 | 2 |
GO:0009798 | axis specification | 4.04e-03 | 1.00e+00 | 7.950 | 1 | 1 | 2 |
GO:0070256 | negative regulation of mucus secretion | 4.04e-03 | 1.00e+00 | 7.950 | 1 | 1 | 2 |
GO:0044324 | regulation of transcription involved in anterior/posterior axis specification | 4.04e-03 | 1.00e+00 | 7.950 | 1 | 1 | 2 |
GO:0042323 | negative regulation of circadian sleep/wake cycle, non-REM sleep | 4.04e-03 | 1.00e+00 | 7.950 | 1 | 1 | 2 |
GO:0003743 | translation initiation factor activity | 4.39e-03 | 1.00e+00 | 4.335 | 2 | 5 | 49 |
GO:0006355 | regulation of transcription, DNA-templated | 5.74e-03 | 1.00e+00 | 1.649 | 7 | 13 | 1104 |
GO:0043103 | hypoxanthine salvage | 6.05e-03 | 1.00e+00 | 7.365 | 1 | 1 | 3 |
GO:0042306 | regulation of protein import into nucleus | 6.05e-03 | 1.00e+00 | 7.365 | 1 | 1 | 3 |
GO:0016149 | translation release factor activity, codon specific | 6.05e-03 | 1.00e+00 | 7.365 | 1 | 1 | 3 |
GO:0033632 | regulation of cell-cell adhesion mediated by integrin | 6.05e-03 | 1.00e+00 | 7.365 | 1 | 1 | 3 |
GO:0046061 | dATP catabolic process | 6.05e-03 | 1.00e+00 | 7.365 | 1 | 1 | 3 |
GO:0006405 | RNA export from nucleus | 6.05e-03 | 1.00e+00 | 7.365 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 6.05e-03 | 1.00e+00 | 7.365 | 1 | 1 | 3 |
GO:0060205 | cytoplasmic membrane-bounded vesicle lumen | 6.05e-03 | 1.00e+00 | 7.365 | 1 | 1 | 3 |
GO:0016020 | membrane | 6.40e-03 | 1.00e+00 | 1.350 | 9 | 27 | 1746 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 6.95e-03 | 1.00e+00 | 3.996 | 2 | 2 | 62 |
GO:0000776 | kinetochore | 7.17e-03 | 1.00e+00 | 3.973 | 2 | 4 | 63 |
GO:0097452 | GAIT complex | 8.06e-03 | 1.00e+00 | 6.950 | 1 | 2 | 4 |
GO:0034273 | ATG1/UKL1 signaling complex | 8.06e-03 | 1.00e+00 | 6.950 | 1 | 1 | 4 |
GO:0060913 | cardiac cell fate determination | 8.06e-03 | 1.00e+00 | 6.950 | 1 | 1 | 4 |
GO:0060486 | Clara cell differentiation | 8.06e-03 | 1.00e+00 | 6.950 | 1 | 1 | 4 |
GO:0008611 | ether lipid biosynthetic process | 8.06e-03 | 1.00e+00 | 6.950 | 1 | 1 | 4 |
GO:0051151 | negative regulation of smooth muscle cell differentiation | 8.06e-03 | 1.00e+00 | 6.950 | 1 | 1 | 4 |
GO:0097167 | circadian regulation of translation | 8.06e-03 | 1.00e+00 | 6.950 | 1 | 1 | 4 |
GO:0003747 | translation release factor activity | 8.06e-03 | 1.00e+00 | 6.950 | 1 | 2 | 4 |
GO:0002636 | positive regulation of germinal center formation | 8.06e-03 | 1.00e+00 | 6.950 | 1 | 1 | 4 |
GO:0006290 | pyrimidine dimer repair | 8.06e-03 | 1.00e+00 | 6.950 | 1 | 1 | 4 |
GO:0002906 | negative regulation of mature B cell apoptotic process | 8.06e-03 | 1.00e+00 | 6.950 | 1 | 1 | 4 |
GO:0006999 | nuclear pore organization | 8.06e-03 | 1.00e+00 | 6.950 | 1 | 1 | 4 |
GO:0044615 | nuclear pore nuclear basket | 8.06e-03 | 1.00e+00 | 6.950 | 1 | 1 | 4 |
GO:0019887 | protein kinase regulator activity | 8.06e-03 | 1.00e+00 | 6.950 | 1 | 1 | 4 |
GO:0001821 | histamine secretion | 8.06e-03 | 1.00e+00 | 6.950 | 1 | 1 | 4 |
GO:0003729 | mRNA binding | 9.53e-03 | 1.00e+00 | 3.760 | 2 | 3 | 73 |
GO:0042826 | histone deacetylase binding | 9.78e-03 | 1.00e+00 | 3.741 | 2 | 2 | 74 |
GO:0001714 | endodermal cell fate specification | 1.01e-02 | 1.00e+00 | 6.628 | 1 | 1 | 5 |
GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process | 1.01e-02 | 1.00e+00 | 6.628 | 1 | 1 | 5 |
GO:0043620 | regulation of DNA-templated transcription in response to stress | 1.01e-02 | 1.00e+00 | 6.628 | 1 | 1 | 5 |
GO:0004000 | adenosine deaminase activity | 1.01e-02 | 1.00e+00 | 6.628 | 1 | 1 | 5 |
GO:0005849 | mRNA cleavage factor complex | 1.01e-02 | 1.00e+00 | 6.628 | 1 | 1 | 5 |
GO:0021960 | anterior commissure morphogenesis | 1.01e-02 | 1.00e+00 | 6.628 | 1 | 1 | 5 |
GO:0002686 | negative regulation of leukocyte migration | 1.01e-02 | 1.00e+00 | 6.628 | 1 | 1 | 5 |
GO:0048742 | regulation of skeletal muscle fiber development | 1.01e-02 | 1.00e+00 | 6.628 | 1 | 1 | 5 |
GO:0006398 | histone mRNA 3'-end processing | 1.01e-02 | 1.00e+00 | 6.628 | 1 | 1 | 5 |
GO:0045292 | mRNA cis splicing, via spliceosome | 1.01e-02 | 1.00e+00 | 6.628 | 1 | 1 | 5 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 1.01e-02 | 1.00e+00 | 6.628 | 1 | 1 | 5 |
GO:0006449 | regulation of translational termination | 1.01e-02 | 1.00e+00 | 6.628 | 1 | 1 | 5 |
GO:0010793 | regulation of mRNA export from nucleus | 1.01e-02 | 1.00e+00 | 6.628 | 1 | 1 | 5 |
GO:0048671 | negative regulation of collateral sprouting | 1.01e-02 | 1.00e+00 | 6.628 | 1 | 1 | 5 |
GO:0070849 | response to epidermal growth factor | 1.01e-02 | 1.00e+00 | 6.628 | 1 | 1 | 5 |
GO:0016071 | mRNA metabolic process | 1.02e-02 | 1.00e+00 | 2.734 | 3 | 8 | 223 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 1.06e-02 | 1.00e+00 | 3.683 | 2 | 2 | 77 |
GO:0071013 | catalytic step 2 spliceosome | 1.11e-02 | 1.00e+00 | 3.646 | 2 | 3 | 79 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 1.16e-02 | 1.00e+00 | 3.610 | 2 | 2 | 81 |
GO:0006412 | translation | 1.17e-02 | 1.00e+00 | 2.658 | 3 | 5 | 235 |
GO:0008762 | UDP-N-acetylmuramate dehydrogenase activity | 1.21e-02 | 1.00e+00 | 6.365 | 1 | 1 | 6 |
GO:0030858 | positive regulation of epithelial cell differentiation | 1.21e-02 | 1.00e+00 | 6.365 | 1 | 1 | 6 |
GO:0050847 | progesterone receptor signaling pathway | 1.21e-02 | 1.00e+00 | 6.365 | 1 | 1 | 6 |
GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 1.21e-02 | 1.00e+00 | 6.365 | 1 | 1 | 6 |
GO:0060509 | Type I pneumocyte differentiation | 1.21e-02 | 1.00e+00 | 6.365 | 1 | 1 | 6 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 1.21e-02 | 1.00e+00 | 6.365 | 1 | 1 | 6 |
GO:0044300 | cerebellar mossy fiber | 1.21e-02 | 1.00e+00 | 6.365 | 1 | 1 | 6 |
GO:0005851 | eukaryotic translation initiation factor 2B complex | 1.21e-02 | 1.00e+00 | 6.365 | 1 | 3 | 6 |
GO:0071679 | commissural neuron axon guidance | 1.21e-02 | 1.00e+00 | 6.365 | 1 | 1 | 6 |
GO:0071204 | histone pre-mRNA 3'end processing complex | 1.21e-02 | 1.00e+00 | 6.365 | 1 | 1 | 6 |
GO:0042382 | paraspeckles | 1.21e-02 | 1.00e+00 | 6.365 | 1 | 2 | 6 |
GO:0008134 | transcription factor binding | 1.32e-02 | 1.00e+00 | 2.592 | 3 | 6 | 246 |
GO:0016070 | RNA metabolic process | 1.34e-02 | 1.00e+00 | 2.587 | 3 | 8 | 247 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 1.36e-02 | 1.00e+00 | 3.491 | 2 | 4 | 88 |
GO:0007091 | metaphase/anaphase transition of mitotic cell cycle | 1.41e-02 | 1.00e+00 | 6.143 | 1 | 1 | 7 |
GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development | 1.41e-02 | 1.00e+00 | 6.143 | 1 | 1 | 7 |
GO:0046825 | regulation of protein export from nucleus | 1.41e-02 | 1.00e+00 | 6.143 | 1 | 2 | 7 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 1.41e-02 | 1.00e+00 | 6.143 | 1 | 1 | 7 |
GO:0002161 | aminoacyl-tRNA editing activity | 1.41e-02 | 1.00e+00 | 6.143 | 1 | 1 | 7 |
GO:0004521 | endoribonuclease activity | 1.41e-02 | 1.00e+00 | 6.143 | 1 | 1 | 7 |
GO:0050862 | positive regulation of T cell receptor signaling pathway | 1.41e-02 | 1.00e+00 | 6.143 | 1 | 1 | 7 |
GO:0006301 | postreplication repair | 1.41e-02 | 1.00e+00 | 6.143 | 1 | 1 | 7 |
GO:0060510 | Type II pneumocyte differentiation | 1.41e-02 | 1.00e+00 | 6.143 | 1 | 1 | 7 |
GO:0006282 | regulation of DNA repair | 1.41e-02 | 1.00e+00 | 6.143 | 1 | 1 | 7 |
GO:0016363 | nuclear matrix | 1.48e-02 | 1.00e+00 | 3.426 | 2 | 5 | 92 |
GO:0045670 | regulation of osteoclast differentiation | 1.61e-02 | 1.00e+00 | 5.950 | 1 | 1 | 8 |
GO:0051292 | nuclear pore complex assembly | 1.61e-02 | 1.00e+00 | 5.950 | 1 | 1 | 8 |
GO:0001955 | blood vessel maturation | 1.61e-02 | 1.00e+00 | 5.950 | 1 | 1 | 8 |
GO:0000339 | RNA cap binding | 1.61e-02 | 1.00e+00 | 5.950 | 1 | 1 | 8 |
GO:0035457 | cellular response to interferon-alpha | 1.61e-02 | 1.00e+00 | 5.950 | 1 | 1 | 8 |
GO:0070244 | negative regulation of thymocyte apoptotic process | 1.61e-02 | 1.00e+00 | 5.950 | 1 | 1 | 8 |
GO:0033089 | positive regulation of T cell differentiation in thymus | 1.61e-02 | 1.00e+00 | 5.950 | 1 | 1 | 8 |
GO:0042405 | nuclear inclusion body | 1.81e-02 | 1.00e+00 | 5.780 | 1 | 1 | 9 |
GO:0071354 | cellular response to interleukin-6 | 1.81e-02 | 1.00e+00 | 5.780 | 1 | 1 | 9 |
GO:0008409 | 5'-3' exonuclease activity | 1.81e-02 | 1.00e+00 | 5.780 | 1 | 1 | 9 |
GO:0033197 | response to vitamin E | 1.81e-02 | 1.00e+00 | 5.780 | 1 | 1 | 9 |
GO:0010388 | cullin deneddylation | 1.81e-02 | 1.00e+00 | 5.780 | 1 | 5 | 9 |
GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex | 1.81e-02 | 1.00e+00 | 5.780 | 1 | 1 | 9 |
GO:0046638 | positive regulation of alpha-beta T cell differentiation | 1.81e-02 | 1.00e+00 | 5.780 | 1 | 1 | 9 |
GO:0006983 | ER overload response | 1.81e-02 | 1.00e+00 | 5.780 | 1 | 1 | 9 |
GO:0043495 | protein anchor | 1.81e-02 | 1.00e+00 | 5.780 | 1 | 1 | 9 |
GO:0048541 | Peyer's patch development | 1.81e-02 | 1.00e+00 | 5.780 | 1 | 1 | 9 |
GO:0005832 | chaperonin-containing T-complex | 1.81e-02 | 1.00e+00 | 5.780 | 1 | 1 | 9 |
GO:0008610 | lipid biosynthetic process | 2.00e-02 | 1.00e+00 | 5.628 | 1 | 1 | 10 |
GO:0002199 | zona pellucida receptor complex | 2.00e-02 | 1.00e+00 | 5.628 | 1 | 1 | 10 |
GO:0045667 | regulation of osteoblast differentiation | 2.00e-02 | 1.00e+00 | 5.628 | 1 | 1 | 10 |
GO:0031274 | positive regulation of pseudopodium assembly | 2.00e-02 | 1.00e+00 | 5.628 | 1 | 1 | 10 |
GO:0006450 | regulation of translational fidelity | 2.00e-02 | 1.00e+00 | 5.628 | 1 | 1 | 10 |
GO:0071949 | FAD binding | 2.00e-02 | 1.00e+00 | 5.628 | 1 | 1 | 10 |
GO:0043101 | purine-containing compound salvage | 2.00e-02 | 1.00e+00 | 5.628 | 1 | 1 | 10 |
GO:0010225 | response to UV-C | 2.00e-02 | 1.00e+00 | 5.628 | 1 | 2 | 10 |
GO:0000731 | DNA synthesis involved in DNA repair | 2.00e-02 | 1.00e+00 | 5.628 | 1 | 1 | 10 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 2.00e-02 | 1.00e+00 | 5.628 | 1 | 1 | 10 |
GO:0030877 | beta-catenin destruction complex | 2.00e-02 | 1.00e+00 | 5.628 | 1 | 1 | 10 |
GO:0005845 | mRNA cap binding complex | 2.20e-02 | 1.00e+00 | 5.491 | 1 | 1 | 11 |
GO:0051010 | microtubule plus-end binding | 2.20e-02 | 1.00e+00 | 5.491 | 1 | 2 | 11 |
GO:0007340 | acrosome reaction | 2.20e-02 | 1.00e+00 | 5.491 | 1 | 1 | 11 |
GO:0045662 | negative regulation of myoblast differentiation | 2.20e-02 | 1.00e+00 | 5.491 | 1 | 1 | 11 |
GO:0031116 | positive regulation of microtubule polymerization | 2.20e-02 | 1.00e+00 | 5.491 | 1 | 1 | 11 |
GO:0035413 | positive regulation of catenin import into nucleus | 2.20e-02 | 1.00e+00 | 5.491 | 1 | 1 | 11 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 2.20e-02 | 1.00e+00 | 5.491 | 1 | 1 | 11 |
GO:0042162 | telomeric DNA binding | 2.20e-02 | 1.00e+00 | 5.491 | 1 | 1 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 2.20e-02 | 1.00e+00 | 5.491 | 1 | 1 | 11 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 2.22e-02 | 1.00e+00 | 3.117 | 2 | 3 | 114 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 2 | 12 |
GO:0032886 | regulation of microtubule-based process | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 1 | 12 |
GO:0045947 | negative regulation of translational initiation | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 1 | 12 |
GO:0008334 | histone mRNA metabolic process | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 1 | 12 |
GO:0045295 | gamma-catenin binding | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 1 | 12 |
GO:0019079 | viral genome replication | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 1 | 12 |
GO:0034045 | pre-autophagosomal structure membrane | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 1 | 12 |
GO:0008143 | poly(A) binding | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 2 | 12 |
GO:0034399 | nuclear periphery | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 1 | 12 |
GO:0043488 | regulation of mRNA stability | 2.60e-02 | 1.00e+00 | 5.250 | 1 | 1 | 13 |
GO:0010001 | glial cell differentiation | 2.60e-02 | 1.00e+00 | 5.250 | 1 | 1 | 13 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 2.60e-02 | 1.00e+00 | 5.250 | 1 | 1 | 13 |
GO:0010460 | positive regulation of heart rate | 2.60e-02 | 1.00e+00 | 5.250 | 1 | 1 | 13 |
GO:0044295 | axonal growth cone | 2.60e-02 | 1.00e+00 | 5.250 | 1 | 1 | 13 |
GO:0051019 | mitogen-activated protein kinase binding | 2.60e-02 | 1.00e+00 | 5.250 | 1 | 2 | 13 |
GO:0043409 | negative regulation of MAPK cascade | 2.60e-02 | 1.00e+00 | 5.250 | 1 | 2 | 13 |
GO:0005868 | cytoplasmic dynein complex | 2.60e-02 | 1.00e+00 | 5.250 | 1 | 1 | 13 |
GO:0035198 | miRNA binding | 2.60e-02 | 1.00e+00 | 5.250 | 1 | 1 | 13 |
GO:0046827 | positive regulation of protein export from nucleus | 2.60e-02 | 1.00e+00 | 5.250 | 1 | 1 | 13 |
GO:0007050 | cell cycle arrest | 2.67e-02 | 1.00e+00 | 2.973 | 2 | 3 | 126 |
GO:0035371 | microtubule plus-end | 2.79e-02 | 1.00e+00 | 5.143 | 1 | 1 | 14 |
GO:0071480 | cellular response to gamma radiation | 2.79e-02 | 1.00e+00 | 5.143 | 1 | 1 | 14 |
GO:0048566 | embryonic digestive tract development | 2.79e-02 | 1.00e+00 | 5.143 | 1 | 1 | 14 |
GO:0005095 | GTPase inhibitor activity | 2.79e-02 | 1.00e+00 | 5.143 | 1 | 1 | 14 |
GO:0045807 | positive regulation of endocytosis | 2.79e-02 | 1.00e+00 | 5.143 | 1 | 1 | 14 |
GO:0032465 | regulation of cytokinesis | 2.79e-02 | 1.00e+00 | 5.143 | 1 | 1 | 14 |
GO:0005487 | nucleocytoplasmic transporter activity | 2.79e-02 | 1.00e+00 | 5.143 | 1 | 2 | 14 |
GO:0030335 | positive regulation of cell migration | 2.83e-02 | 1.00e+00 | 2.928 | 2 | 2 | 130 |
GO:0006413 | translational initiation | 2.87e-02 | 1.00e+00 | 2.917 | 2 | 4 | 131 |
GO:0016477 | cell migration | 2.87e-02 | 1.00e+00 | 2.917 | 2 | 2 | 131 |
GO:0042307 | positive regulation of protein import into nucleus | 2.99e-02 | 1.00e+00 | 5.043 | 1 | 2 | 15 |
GO:0017091 | AU-rich element binding | 2.99e-02 | 1.00e+00 | 5.043 | 1 | 2 | 15 |
GO:0006479 | protein methylation | 2.99e-02 | 1.00e+00 | 5.043 | 1 | 2 | 15 |
GO:0001824 | blastocyst development | 2.99e-02 | 1.00e+00 | 5.043 | 1 | 1 | 15 |
GO:0006401 | RNA catabolic process | 2.99e-02 | 1.00e+00 | 5.043 | 1 | 1 | 15 |
GO:0045987 | positive regulation of smooth muscle contraction | 2.99e-02 | 1.00e+00 | 5.043 | 1 | 1 | 15 |
GO:0032839 | dendrite cytoplasm | 3.19e-02 | 1.00e+00 | 4.950 | 1 | 1 | 16 |
GO:0007026 | negative regulation of microtubule depolymerization | 3.19e-02 | 1.00e+00 | 4.950 | 1 | 2 | 16 |
GO:0030902 | hindbrain development | 3.19e-02 | 1.00e+00 | 4.950 | 1 | 1 | 16 |
GO:0046716 | muscle cell cellular homeostasis | 3.19e-02 | 1.00e+00 | 4.950 | 1 | 1 | 16 |
GO:0051276 | chromosome organization | 3.19e-02 | 1.00e+00 | 4.950 | 1 | 2 | 16 |
GO:0001829 | trophectodermal cell differentiation | 3.38e-02 | 1.00e+00 | 4.863 | 1 | 2 | 17 |
GO:0043274 | phospholipase binding | 3.38e-02 | 1.00e+00 | 4.863 | 1 | 1 | 17 |
GO:0005215 | transporter activity | 3.46e-02 | 1.00e+00 | 2.770 | 2 | 2 | 145 |
GO:0070064 | proline-rich region binding | 3.58e-02 | 1.00e+00 | 4.780 | 1 | 1 | 18 |
GO:0031122 | cytoplasmic microtubule organization | 3.58e-02 | 1.00e+00 | 4.780 | 1 | 1 | 18 |
GO:0090316 | positive regulation of intracellular protein transport | 3.58e-02 | 1.00e+00 | 4.780 | 1 | 1 | 18 |
GO:0001077 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 3.72e-02 | 1.00e+00 | 2.712 | 2 | 2 | 151 |
GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity | 3.77e-02 | 1.00e+00 | 4.702 | 1 | 2 | 19 |
GO:0050850 | positive regulation of calcium-mediated signaling | 3.97e-02 | 1.00e+00 | 4.628 | 1 | 1 | 20 |
GO:0046777 | protein autophosphorylation | 4.04e-02 | 1.00e+00 | 2.646 | 2 | 3 | 158 |
GO:0048675 | axon extension | 4.16e-02 | 1.00e+00 | 4.558 | 1 | 1 | 21 |
GO:0032757 | positive regulation of interleukin-8 production | 4.16e-02 | 1.00e+00 | 4.558 | 1 | 1 | 21 |
GO:0009954 | proximal/distal pattern formation | 4.16e-02 | 1.00e+00 | 4.558 | 1 | 1 | 21 |
GO:0043278 | response to morphine | 4.16e-02 | 1.00e+00 | 4.558 | 1 | 1 | 21 |
GO:0016575 | histone deacetylation | 4.16e-02 | 1.00e+00 | 4.558 | 1 | 1 | 21 |
GO:0000281 | mitotic cytokinesis | 4.16e-02 | 1.00e+00 | 4.558 | 1 | 1 | 21 |
GO:0001106 | RNA polymerase II transcription corepressor activity | 4.36e-02 | 1.00e+00 | 4.491 | 1 | 1 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 4.36e-02 | 1.00e+00 | 4.491 | 1 | 1 | 22 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 4.52e-02 | 1.00e+00 | 2.558 | 2 | 3 | 168 |
GO:0010506 | regulation of autophagy | 4.55e-02 | 1.00e+00 | 4.426 | 1 | 1 | 23 |
GO:0071346 | cellular response to interferon-gamma | 4.55e-02 | 1.00e+00 | 4.426 | 1 | 2 | 23 |
GO:0034660 | ncRNA metabolic process | 4.55e-02 | 1.00e+00 | 4.426 | 1 | 1 | 23 |
GO:0006397 | mRNA processing | 4.56e-02 | 1.00e+00 | 2.549 | 2 | 6 | 169 |
GO:0008135 | translation factor activity, nucleic acid binding | 4.74e-02 | 1.00e+00 | 4.365 | 1 | 2 | 24 |
GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 4.74e-02 | 1.00e+00 | 4.365 | 1 | 1 | 24 |
GO:0016607 | nuclear speck | 4.86e-02 | 1.00e+00 | 2.499 | 2 | 6 | 175 |
GO:0006611 | protein export from nucleus | 4.94e-02 | 1.00e+00 | 4.306 | 1 | 1 | 25 |
GO:0030864 | cortical actin cytoskeleton | 4.94e-02 | 1.00e+00 | 4.306 | 1 | 1 | 25 |
GO:0005844 | polysome | 4.94e-02 | 1.00e+00 | 4.306 | 1 | 2 | 25 |
GO:0045296 | cadherin binding | 4.94e-02 | 1.00e+00 | 4.306 | 1 | 1 | 25 |
GO:0007049 | cell cycle | 4.96e-02 | 1.00e+00 | 2.482 | 2 | 4 | 177 |
GO:0003714 | transcription corepressor activity | 5.06e-02 | 1.00e+00 | 2.466 | 2 | 5 | 179 |
GO:0035329 | hippo signaling | 5.13e-02 | 1.00e+00 | 4.250 | 1 | 1 | 26 |
GO:0031047 | gene silencing by RNA | 5.13e-02 | 1.00e+00 | 4.250 | 1 | 2 | 26 |
GO:0000045 | autophagic vacuole assembly | 5.13e-02 | 1.00e+00 | 4.250 | 1 | 1 | 26 |
GO:0051209 | release of sequestered calcium ion into cytosol | 5.13e-02 | 1.00e+00 | 4.250 | 1 | 2 | 26 |
GO:0006913 | nucleocytoplasmic transport | 5.32e-02 | 1.00e+00 | 4.195 | 1 | 1 | 27 |
GO:0000188 | inactivation of MAPK activity | 5.32e-02 | 1.00e+00 | 4.195 | 1 | 1 | 27 |
GO:0043392 | negative regulation of DNA binding | 5.32e-02 | 1.00e+00 | 4.195 | 1 | 1 | 27 |
GO:0000387 | spliceosomal snRNP assembly | 5.32e-02 | 1.00e+00 | 4.195 | 1 | 1 | 27 |
GO:0007339 | binding of sperm to zona pellucida | 5.32e-02 | 1.00e+00 | 4.195 | 1 | 1 | 27 |
GO:0005637 | nuclear inner membrane | 5.51e-02 | 1.00e+00 | 4.143 | 1 | 1 | 28 |
GO:0015631 | tubulin binding | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 1 | 29 |
GO:0005913 | cell-cell adherens junction | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 1 | 29 |
GO:0005739 | mitochondrion | 5.71e-02 | 1.00e+00 | 1.241 | 5 | 16 | 1046 |
GO:0003887 | DNA-directed DNA polymerase activity | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 1 | 29 |
GO:0034605 | cellular response to heat | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 1 | 29 |
GO:0072686 | mitotic spindle | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 1 | 29 |
GO:0071897 | DNA biosynthetic process | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 1 | 29 |
GO:0006606 | protein import into nucleus | 5.90e-02 | 1.00e+00 | 4.043 | 1 | 1 | 30 |
GO:0006370 | 7-methylguanosine mRNA capping | 5.90e-02 | 1.00e+00 | 4.043 | 1 | 2 | 30 |
GO:0031647 | regulation of protein stability | 5.90e-02 | 1.00e+00 | 4.043 | 1 | 2 | 30 |
GO:0051262 | protein tetramerization | 5.90e-02 | 1.00e+00 | 4.043 | 1 | 1 | 30 |
GO:0010494 | cytoplasmic stress granule | 5.90e-02 | 1.00e+00 | 4.043 | 1 | 2 | 30 |
GO:0010827 | regulation of glucose transport | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 3 | 31 |
GO:0005782 | peroxisomal matrix | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 1 | 31 |
GO:0009953 | dorsal/ventral pattern formation | 6.28e-02 | 1.00e+00 | 3.950 | 1 | 1 | 32 |
GO:0006144 | purine nucleobase metabolic process | 6.28e-02 | 1.00e+00 | 3.950 | 1 | 2 | 32 |
GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic | 6.28e-02 | 1.00e+00 | 3.950 | 1 | 1 | 32 |
GO:0002062 | chondrocyte differentiation | 6.28e-02 | 1.00e+00 | 3.950 | 1 | 2 | 32 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 6.28e-02 | 1.00e+00 | 3.950 | 1 | 1 | 32 |
GO:0033077 | T cell differentiation in thymus | 6.47e-02 | 1.00e+00 | 3.906 | 1 | 1 | 33 |
GO:0007162 | negative regulation of cell adhesion | 6.47e-02 | 1.00e+00 | 3.906 | 1 | 1 | 33 |
GO:0031072 | heat shock protein binding | 6.47e-02 | 1.00e+00 | 3.906 | 1 | 1 | 33 |
GO:0001104 | RNA polymerase II transcription cofactor activity | 6.47e-02 | 1.00e+00 | 3.906 | 1 | 3 | 33 |
GO:0070830 | tight junction assembly | 6.47e-02 | 1.00e+00 | 3.906 | 1 | 1 | 33 |
GO:0008180 | COP9 signalosome | 6.66e-02 | 1.00e+00 | 3.863 | 1 | 6 | 34 |
GO:0001890 | placenta development | 6.66e-02 | 1.00e+00 | 3.863 | 1 | 1 | 34 |
GO:0048286 | lung alveolus development | 6.66e-02 | 1.00e+00 | 3.863 | 1 | 1 | 34 |
GO:0001942 | hair follicle development | 6.85e-02 | 1.00e+00 | 3.821 | 1 | 1 | 35 |
GO:0030890 | positive regulation of B cell proliferation | 6.85e-02 | 1.00e+00 | 3.821 | 1 | 1 | 35 |
GO:0009267 | cellular response to starvation | 7.03e-02 | 1.00e+00 | 3.780 | 1 | 1 | 36 |
GO:0048538 | thymus development | 7.03e-02 | 1.00e+00 | 3.780 | 1 | 1 | 36 |
GO:0006446 | regulation of translational initiation | 7.03e-02 | 1.00e+00 | 3.780 | 1 | 2 | 36 |
GO:0007077 | mitotic nuclear envelope disassembly | 7.22e-02 | 1.00e+00 | 3.741 | 1 | 3 | 37 |
GO:0051084 | 'de novo' posttranslational protein folding | 7.22e-02 | 1.00e+00 | 3.741 | 1 | 1 | 37 |
GO:0042752 | regulation of circadian rhythm | 7.22e-02 | 1.00e+00 | 3.741 | 1 | 3 | 37 |
GO:0045893 | positive regulation of transcription, DNA-templated | 7.45e-02 | 1.00e+00 | 1.607 | 3 | 6 | 487 |
GO:0051781 | positive regulation of cell division | 7.60e-02 | 1.00e+00 | 3.665 | 1 | 1 | 39 |
GO:0042542 | response to hydrogen peroxide | 7.79e-02 | 1.00e+00 | 3.628 | 1 | 1 | 40 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 7.92e-02 | 1.00e+00 | 1.286 | 4 | 13 | 811 |
GO:0005881 | cytoplasmic microtubule | 7.97e-02 | 1.00e+00 | 3.592 | 1 | 2 | 41 |
GO:0045785 | positive regulation of cell adhesion | 7.97e-02 | 1.00e+00 | 3.592 | 1 | 1 | 41 |
GO:0017148 | negative regulation of translation | 7.97e-02 | 1.00e+00 | 3.592 | 1 | 3 | 41 |
GO:0006418 | tRNA aminoacylation for protein translation | 8.16e-02 | 1.00e+00 | 3.558 | 1 | 3 | 42 |
GO:0008645 | hexose transport | 8.16e-02 | 1.00e+00 | 3.558 | 1 | 3 | 42 |
GO:0042110 | T cell activation | 8.35e-02 | 1.00e+00 | 3.524 | 1 | 2 | 43 |
GO:0014070 | response to organic cyclic compound | 8.35e-02 | 1.00e+00 | 3.524 | 1 | 1 | 43 |
GO:0005737 | cytoplasm | 8.39e-02 | 1.00e+00 | 0.578 | 12 | 43 | 3976 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 8.53e-02 | 1.00e+00 | 3.491 | 1 | 1 | 44 |
GO:0050434 | positive regulation of viral transcription | 8.53e-02 | 1.00e+00 | 3.491 | 1 | 2 | 44 |
GO:0016328 | lateral plasma membrane | 8.90e-02 | 1.00e+00 | 3.426 | 1 | 1 | 46 |
GO:0044297 | cell body | 8.90e-02 | 1.00e+00 | 3.426 | 1 | 1 | 46 |
GO:0043525 | positive regulation of neuron apoptotic process | 8.90e-02 | 1.00e+00 | 3.426 | 1 | 2 | 46 |
GO:0019898 | extrinsic component of membrane | 8.90e-02 | 1.00e+00 | 3.426 | 1 | 1 | 46 |
GO:0045727 | positive regulation of translation | 8.90e-02 | 1.00e+00 | 3.426 | 1 | 2 | 46 |
GO:0006921 | cellular component disassembly involved in execution phase of apoptosis | 9.09e-02 | 1.00e+00 | 3.395 | 1 | 1 | 47 |
GO:0019827 | stem cell maintenance | 9.27e-02 | 1.00e+00 | 3.365 | 1 | 2 | 48 |
GO:0004842 | ubiquitin-protein transferase activity | 9.42e-02 | 1.00e+00 | 1.950 | 2 | 5 | 256 |
GO:0016032 | viral process | 9.47e-02 | 1.00e+00 | 1.458 | 3 | 16 | 540 |
GO:0005778 | peroxisomal membrane | 9.64e-02 | 1.00e+00 | 3.306 | 1 | 2 | 50 |
GO:0006986 | response to unfolded protein | 9.82e-02 | 1.00e+00 | 3.278 | 1 | 2 | 51 |
GO:0001669 | acrosomal vesicle | 9.82e-02 | 1.00e+00 | 3.278 | 1 | 1 | 51 |
GO:0007254 | JNK cascade | 9.82e-02 | 1.00e+00 | 3.278 | 1 | 2 | 51 |
GO:0003684 | damaged DNA binding | 9.82e-02 | 1.00e+00 | 3.278 | 1 | 1 | 51 |
GO:0045732 | positive regulation of protein catabolic process | 9.82e-02 | 1.00e+00 | 3.278 | 1 | 1 | 51 |
GO:0034976 | response to endoplasmic reticulum stress | 1.00e-01 | 1.00e+00 | 3.250 | 1 | 1 | 52 |
GO:0045454 | cell redox homeostasis | 1.00e-01 | 1.00e+00 | 3.250 | 1 | 1 | 52 |
GO:0009611 | response to wounding | 1.02e-01 | 1.00e+00 | 3.222 | 1 | 1 | 53 |
GO:0060041 | retina development in camera-type eye | 1.02e-01 | 1.00e+00 | 3.222 | 1 | 1 | 53 |
GO:0048306 | calcium-dependent protein binding | 1.09e-01 | 1.00e+00 | 3.117 | 1 | 1 | 57 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 1.13e-01 | 1.00e+00 | 3.067 | 1 | 2 | 59 |
GO:0015758 | glucose transport | 1.13e-01 | 1.00e+00 | 3.067 | 1 | 3 | 59 |
GO:0005643 | nuclear pore | 1.13e-01 | 1.00e+00 | 3.067 | 1 | 3 | 59 |
GO:0050728 | negative regulation of inflammatory response | 1.15e-01 | 1.00e+00 | 3.043 | 1 | 1 | 60 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 1.15e-01 | 1.00e+00 | 1.333 | 3 | 10 | 589 |
GO:0008013 | beta-catenin binding | 1.15e-01 | 1.00e+00 | 3.043 | 1 | 4 | 60 |
GO:0005730 | nucleolus | 1.19e-01 | 1.00e+00 | 0.817 | 6 | 28 | 1684 |
GO:0000151 | ubiquitin ligase complex | 1.20e-01 | 1.00e+00 | 2.973 | 1 | 2 | 63 |
GO:0007409 | axonogenesis | 1.25e-01 | 1.00e+00 | 2.906 | 1 | 1 | 66 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 1.27e-01 | 1.00e+00 | 2.884 | 1 | 3 | 67 |
GO:0016787 | hydrolase activity | 1.32e-01 | 1.00e+00 | 2.821 | 1 | 1 | 70 |
GO:0032587 | ruffle membrane | 1.36e-01 | 1.00e+00 | 2.780 | 1 | 1 | 72 |
GO:0010468 | regulation of gene expression | 1.36e-01 | 1.00e+00 | 2.780 | 1 | 1 | 72 |
GO:0008021 | synaptic vesicle | 1.38e-01 | 1.00e+00 | 2.760 | 1 | 2 | 73 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 1.38e-01 | 1.00e+00 | 2.760 | 1 | 2 | 73 |
GO:0060070 | canonical Wnt signaling pathway | 1.41e-01 | 1.00e+00 | 2.721 | 1 | 2 | 75 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 1.43e-01 | 1.00e+00 | 2.702 | 1 | 2 | 76 |
GO:0008584 | male gonad development | 1.45e-01 | 1.00e+00 | 2.683 | 1 | 1 | 77 |
GO:0001822 | kidney development | 1.48e-01 | 1.00e+00 | 2.646 | 1 | 2 | 79 |
GO:0005813 | centrosome | 1.49e-01 | 1.00e+00 | 1.545 | 2 | 4 | 339 |
GO:0051301 | cell division | 1.52e-01 | 1.00e+00 | 2.610 | 1 | 2 | 81 |
GO:0001889 | liver development | 1.53e-01 | 1.00e+00 | 2.592 | 1 | 2 | 82 |
GO:0009952 | anterior/posterior pattern specification | 1.57e-01 | 1.00e+00 | 2.558 | 1 | 2 | 84 |
GO:0009653 | anatomical structure morphogenesis | 1.62e-01 | 1.00e+00 | 2.507 | 1 | 1 | 87 |
GO:0006415 | translational termination | 1.62e-01 | 1.00e+00 | 2.507 | 1 | 2 | 87 |
GO:0006464 | cellular protein modification process | 1.65e-01 | 1.00e+00 | 2.474 | 1 | 1 | 89 |
GO:0005777 | peroxisome | 1.67e-01 | 1.00e+00 | 2.458 | 1 | 1 | 90 |
GO:0043565 | sequence-specific DNA binding | 1.68e-01 | 1.00e+00 | 1.438 | 2 | 3 | 365 |
GO:0008285 | negative regulation of cell proliferation | 1.69e-01 | 1.00e+00 | 1.430 | 2 | 4 | 367 |
GO:0003690 | double-stranded DNA binding | 1.69e-01 | 1.00e+00 | 2.442 | 1 | 1 | 91 |
GO:0016337 | single organismal cell-cell adhesion | 1.70e-01 | 1.00e+00 | 2.426 | 1 | 1 | 92 |
GO:0005923 | tight junction | 1.70e-01 | 1.00e+00 | 2.426 | 1 | 1 | 92 |
GO:0005770 | late endosome | 1.74e-01 | 1.00e+00 | 2.395 | 1 | 1 | 94 |
GO:0051082 | unfolded protein binding | 1.75e-01 | 1.00e+00 | 2.380 | 1 | 3 | 95 |
GO:0007010 | cytoskeleton organization | 1.77e-01 | 1.00e+00 | 2.365 | 1 | 1 | 96 |
GO:0030018 | Z disc | 1.80e-01 | 1.00e+00 | 2.335 | 1 | 2 | 98 |
GO:0007155 | cell adhesion | 1.82e-01 | 1.00e+00 | 1.365 | 2 | 2 | 384 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 1.91e-01 | 1.00e+00 | 0.988 | 3 | 10 | 748 |
GO:0008360 | regulation of cell shape | 1.94e-01 | 1.00e+00 | 2.222 | 1 | 1 | 106 |
GO:0030659 | cytoplasmic vesicle membrane | 1.95e-01 | 1.00e+00 | 2.209 | 1 | 1 | 107 |
GO:0006461 | protein complex assembly | 2.02e-01 | 1.00e+00 | 2.156 | 1 | 2 | 111 |
GO:0030308 | negative regulation of cell growth | 2.05e-01 | 1.00e+00 | 2.130 | 1 | 2 | 113 |
GO:0000209 | protein polyubiquitination | 2.10e-01 | 1.00e+00 | 2.092 | 1 | 5 | 116 |
GO:0005635 | nuclear envelope | 2.10e-01 | 1.00e+00 | 2.092 | 1 | 3 | 116 |
GO:0009986 | cell surface | 2.10e-01 | 1.00e+00 | 1.229 | 2 | 4 | 422 |
GO:0045892 | negative regulation of transcription, DNA-templated | 2.11e-01 | 1.00e+00 | 1.222 | 2 | 7 | 424 |
GO:0007568 | aging | 2.21e-01 | 1.00e+00 | 2.008 | 1 | 2 | 123 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 2.27e-01 | 1.00e+00 | 1.961 | 1 | 3 | 127 |
GO:0030027 | lamellipodium | 2.32e-01 | 1.00e+00 | 1.928 | 1 | 1 | 130 |
GO:0044255 | cellular lipid metabolic process | 2.48e-01 | 1.00e+00 | 1.821 | 1 | 1 | 140 |
GO:0016055 | Wnt signaling pathway | 2.49e-01 | 1.00e+00 | 1.810 | 1 | 3 | 141 |
GO:0042802 | identical protein binding | 2.61e-01 | 1.00e+00 | 1.010 | 2 | 6 | 491 |
GO:0006457 | protein folding | 2.61e-01 | 1.00e+00 | 1.731 | 1 | 1 | 149 |
GO:0008017 | microtubule binding | 2.63e-01 | 1.00e+00 | 1.721 | 1 | 4 | 150 |
GO:0001666 | response to hypoxia | 2.63e-01 | 1.00e+00 | 1.721 | 1 | 3 | 150 |
GO:0042981 | regulation of apoptotic process | 2.64e-01 | 1.00e+00 | 1.712 | 1 | 3 | 151 |
GO:0005198 | structural molecule activity | 2.76e-01 | 1.00e+00 | 1.637 | 1 | 1 | 159 |
GO:0003677 | DNA binding | 2.90e-01 | 1.00e+00 | 0.550 | 4 | 16 | 1351 |
GO:0005524 | ATP binding | 2.91e-01 | 1.00e+00 | 0.547 | 4 | 13 | 1354 |
GO:0031965 | nuclear membrane | 3.01e-01 | 1.00e+00 | 1.491 | 1 | 1 | 176 |
GO:0005667 | transcription factor complex | 3.04e-01 | 1.00e+00 | 1.474 | 1 | 3 | 178 |
GO:0031625 | ubiquitin protein ligase binding | 3.07e-01 | 1.00e+00 | 1.458 | 1 | 2 | 180 |
GO:0005764 | lysosome | 3.10e-01 | 1.00e+00 | 1.442 | 1 | 1 | 182 |
GO:0009897 | external side of plasma membrane | 3.11e-01 | 1.00e+00 | 1.434 | 1 | 1 | 183 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 3.12e-01 | 1.00e+00 | 1.426 | 1 | 5 | 184 |
GO:0001701 | in utero embryonic development | 3.48e-01 | 1.00e+00 | 1.236 | 1 | 2 | 210 |
GO:0042803 | protein homodimerization activity | 3.56e-01 | 1.00e+00 | 0.681 | 2 | 6 | 617 |
GO:0008270 | zinc ion binding | 3.67e-01 | 1.00e+00 | 0.476 | 3 | 11 | 1067 |
GO:0016874 | ligase activity | 3.67e-01 | 1.00e+00 | 1.143 | 1 | 4 | 224 |
GO:0019221 | cytokine-mediated signaling pathway | 3.74e-01 | 1.00e+00 | 1.105 | 1 | 3 | 230 |
GO:0007067 | mitotic nuclear division | 3.76e-01 | 1.00e+00 | 1.098 | 1 | 4 | 231 |
GO:0003713 | transcription coactivator activity | 3.86e-01 | 1.00e+00 | 1.049 | 1 | 7 | 239 |
GO:0043025 | neuronal cell body | 4.04e-01 | 1.00e+00 | 0.961 | 1 | 3 | 254 |
GO:0005874 | microtubule | 4.09e-01 | 1.00e+00 | 0.939 | 1 | 3 | 258 |
GO:0006281 | DNA repair | 4.16e-01 | 1.00e+00 | 0.906 | 1 | 4 | 264 |
GO:0005975 | carbohydrate metabolic process | 4.28e-01 | 1.00e+00 | 0.852 | 1 | 3 | 274 |
GO:0043065 | positive regulation of apoptotic process | 4.28e-01 | 1.00e+00 | 0.852 | 1 | 3 | 274 |
GO:0003779 | actin binding | 4.30e-01 | 1.00e+00 | 0.847 | 1 | 1 | 275 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 4.30e-01 | 1.00e+00 | 0.847 | 1 | 4 | 275 |
GO:0042493 | response to drug | 4.45e-01 | 1.00e+00 | 0.780 | 1 | 1 | 288 |
GO:0019899 | enzyme binding | 4.45e-01 | 1.00e+00 | 0.780 | 1 | 3 | 288 |
GO:0016567 | protein ubiquitination | 4.57e-01 | 1.00e+00 | 0.726 | 1 | 5 | 299 |
GO:0005743 | mitochondrial inner membrane | 4.58e-01 | 1.00e+00 | 0.721 | 1 | 3 | 300 |
GO:0004674 | protein serine/threonine kinase activity | 4.71e-01 | 1.00e+00 | 0.665 | 1 | 2 | 312 |
GO:0019901 | protein kinase binding | 4.80e-01 | 1.00e+00 | 0.628 | 1 | 4 | 320 |
GO:0008283 | cell proliferation | 4.92e-01 | 1.00e+00 | 0.579 | 1 | 3 | 331 |
GO:0044281 | small molecule metabolic process | 4.93e-01 | 1.00e+00 | 0.196 | 3 | 12 | 1295 |
GO:0043231 | intracellular membrane-bounded organelle | 4.93e-01 | 1.00e+00 | 0.575 | 1 | 1 | 332 |
GO:0003682 | chromatin binding | 4.95e-01 | 1.00e+00 | 0.566 | 1 | 7 | 334 |
GO:0030054 | cell junction | 5.17e-01 | 1.00e+00 | 0.474 | 1 | 3 | 356 |
GO:0000278 | mitotic cell cycle | 5.58e-01 | 1.00e+00 | 0.313 | 1 | 12 | 398 |
GO:0046982 | protein heterodimerization activity | 5.59e-01 | 1.00e+00 | 0.310 | 1 | 3 | 399 |
GO:0046872 | metal ion binding | 5.79e-01 | 1.00e+00 | 0.018 | 3 | 6 | 1465 |
GO:0007165 | signal transduction | 5.80e-01 | 1.00e+00 | 0.058 | 2 | 8 | 950 |
GO:0055114 | oxidation-reduction process | 6.28e-01 | 1.00e+00 | 0.040 | 1 | 2 | 481 |
GO:0006351 | transcription, DNA-templated | 6.34e-01 | 1.00e+00 | -0.095 | 3 | 17 | 1585 |
GO:0055085 | transmembrane transport | 6.53e-01 | 1.00e+00 | -0.056 | 1 | 5 | 514 |
GO:0006915 | apoptotic process | 6.92e-01 | 1.00e+00 | -0.207 | 1 | 8 | 571 |
GO:0005783 | endoplasmic reticulum | 7.16e-01 | 1.00e+00 | -0.303 | 1 | 2 | 610 |
GO:0070062 | extracellular vesicular exosome | 7.71e-01 | 1.00e+00 | -0.347 | 4 | 15 | 2516 |
GO:0005886 | plasma membrane | 8.49e-01 | 1.00e+00 | -0.519 | 4 | 14 | 2834 |
GO:0005887 | integral component of plasma membrane | 8.65e-01 | 1.00e+00 | -0.958 | 1 | 1 | 961 |
GO:0005615 | extracellular space | 8.79e-01 | 1.00e+00 | -1.030 | 1 | 4 | 1010 |
GO:0016021 | integral component of membrane | 9.96e-01 | 1.00e+00 | -2.328 | 1 | 7 | 2483 |